AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionVirtue Capital Management, LLC
Latest Disclosed Ownership4,166 shares
Latest Disclosed Value $ 887,825
Virtue Capital Management, LLC reports 6.96% increase in ownership of 4AB / AbbVie Inc.

On May 7, 2026 - Virtue Capital Management, LLC filed a 13F-HR form disclosing ownership of 4,166 shares of AbbVie Inc. (BG:4AB) valued at $887,825 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 18, 2026 disclosing 3,895 shares of AbbVie Inc.. This represents a change in shares of 6.96% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ABBVIE COM 00287Y109 4,166 271 6.96 888 -0.67 0.1351
2026-02-18 2025-12-31 13F/A-1 ABBVIE COM 00287Y109 3,895 -2,035 -34.32 893 24.03 0.1376
2026-02-12 2025-12-31 13F ABBOTT LABS COM 00287Y109 1,734 -1,107 215
2026-02-18 2025-09-30 13F/A-1 ABBVIE COM 00287Y109 5,930 2,554 75.65 720 15.02 0.1147
2025-10-31 2025-09-30 13F ABBOTT LABS COM 00287Y109 2,841 -535 658 0.1048
2025-08-13 2025-06-30 13F ABBVIE COM 00287Y109 3,376 -1,371 -28.88 627 -36.96 0.1153
2025-05-15 2025-03-31 13F ABBVIE COM 00287Y109 4,747 683 16.81 993 37.53 0.1161
2025-02-26 2024-12-31 13F ABBVIE COM 00287Y109 4,064 -692 -14.55 722 -23.11 0.1454
2024-11-18 2024-09-30 13F ABBVIE COM 00287Y109 4,756 -315 -6.21 939 6.83 0.1880
2024-08-13 2024-06-30 13F ABBVIE COM 00287Y109 5,071 798 18.68 879 27.02 0.1506
2024-05-15 2024-03-31 13F ABBVIE COM 00287Y109 4,273 -289 -6.33 692 -6.23 0.1244
2024-02-15 2023-12-31 13F ABBVIE COM 00287Y109 4,562 -814 -15.14 739 -0.14 0.1498
2023-11-14 2023-09-30 13F ABBVIE INC COM COM 00287Y109 5,376 0 0.00 740 0.00 0.1260
2023-07-18 2023-06-30 13F ABBVIE INC COM COM 00287Y109 5,376 -33 -0.61 740 -15.54 0.1262
2023-05-11 2023-03-31 13F ABBVIE INC COM COM 00287Y109 5,409 -379 -6.55 875 -6.42 0.1432
2023-02-10 2022-12-31 13F ABBVIE INC COM COM 00287Y109 5,788 5,788 935 0.1428
2022-08-10 2022-06-30 13F ABBVIE INC COM COM 00287Y109 0 -11,777 -100.00 0 -100.00
2022-05-16 2022-03-31 13F ABBVIE INC COM COM 00287Y109 11,777 6,698 131.88 1,909 177.47 0.3008
2022-01-24 2021-12-31 13F ABBVIE INC COM COM 00287Y109 5,079 1,222 31.68 688 65.38 0.1015
2021-11-12 2021-09-30 13F ABBVIE INC COM COM 00287Y109 3,857 -733 -15.97 416 -19.54 0.0737
2021-07-15 2021-06-30 13F ABBVIE INC COM COM 00287Y109 4,590 201 4.58 517 8.84 0.1032
2021-05-13 2021-03-31 13F ABBVIE INC COM COM 00287Y109 4,389 -802 -15.45 475 -14.57 0.1118
2021-02-16 2020-12-31 13F ABBVIE INC COM COM 00287Y109 5,191 -2,367 -31.32 556 -16.01 0.1364
2020-11-16 2020-09-30 13F ABBVIE INC COM COM 00287Y109 7,558 -3,445 -31.31 662 -38.70 0.1630
2020-08-10 2020-06-30 13F ABBVIE INC COM COM 00287Y109 11,003 11,003 1,080 0.2491
2020-05-13 2020-03-31 13F ABBVIE INC COM COM 00287Y109 0 -6,174 -100.00 0 -100.00
2020-02-14 2019-12-31 13F ABBVIE INC COM COM 00287Y109 6,174 -3,290 -34.76 547 -23.71 0.1577
2019-11-12 2019-09-30 13F ABBVIE INC COM COM 00287Y109 9,464 -604 -6.00 717 -2.05 0.2365
2019-11-12 2019-06-30 13F ABBVIE INC COM COM 00287Y109 10,068 10,068 732 0.2661
2019-02-13 2018-12-31 13F AbbVie COM 00287Y109 0 -7,176 -100.00 0 -100.00
2019-02-13 2018-09-30 13F ABBVIE INC COM COM 00287Y109 7,176 2,142 42.55 679 45.71 0.1435
2018-08-14 2018-06-30 13F AbbVie COM 00287Y109 5,034 1,967 64.13 466 62.94 0.2265
2018-05-15 2018-03-31 13F ABBVIE INC COM COM 00287Y109 3,067 1,632 113.73 286 105.76 0.1507
2018-02-14 2017-12-31 13F AbbVie com 00287Y109 1,435 1,435 139 0.0790
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.